Health Tech

FESTIVAL OF BIOLOGICS - EUROPA

The Festival of Biologics Basel is Europe's largest biologics event, covering the industry from discovery to commercialization in antibody, cell and gene therapies, immunotherapies, and biosimilars. It is designed for industry experts, start-ups, academics, regulators, and investors.

Official websiteRegisterAgenda
2 months until it opens.

The essentials

Event details

Dates
13 October 2026 to 15 October 2026
Location
Basel Fairground, Basel, Switzerland
Address
Hall 1, Messe Basel
Organiser
Terrapinn Holdings Ltd
Tickets
EUR 395
Expected attendance
3,000
Industry
Health Tech

Who attends

The audience

Designed for industry experts in pharma and biotech, start-ups, academics, regulators and investors, the Festival of Biologics is the meeting place for the large molecule therapy ecosystem, bringing together 3000+ attendees.

As described by the organiser

Public discussion

What people are saying

Official hashtag #festivalofbiologicsusa

Agenda themes

Topics covered

  • Discovery
  • Development
  • Clinical Trials
  • Manufacturing
  • Market Access
  • Fill & Finish
  • antibody therapies
  • cell and gene therapies
  • immunotherapies
  • biosimilars
  • early stage discovery
  • modality engineering

On stage

Speakers

  • Susanne Diehl, Global Program Head Immunology, VP, Novartis
  • Alain Beck, Senior Director, Biologics CMC and Developability, Pierre Fabre
  • Louis Boon, CSO, JJP Biologics
  • Sophia Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, King's College London
  • Annette Vogl, VP Biology and Translational Research, Tubulis
  • Johan Rockberg, Professor, Antibody Technology and Directed Evolution, KTH Royal Institute of Technology
  • Shaloo Pandhi, CMO, Global Head Patient Safety & Clinical Development, Sandoz
  • Peter Jorgensen, CEO, IGL The Danish Generic and Biosimilars Medicines Industry Association
  • Andreas Pluckthun, Professor of Biochemistry, University of Zurich
  • Enkelejda Miho, Professor, University of Applied Sciences and Arts Northwestern Switzerland FHNW
  • Jonathan Novak, SVP & Global Head Technical R&D Biologics and Cell & gene Therapy, Novartis
  • Stefanie Urlinger, CSO, Cimeio Tx
  • Isabell Remus, Global head of Biosimilars, Sandoz
  • Mourad Rezk, Independent Global Biotech and Biosimilars Executive
  • Andreas Seidl, CSO, Formycon AG
  • Lydia Michault, Director Scientific Governance PK Sciences, Novartis

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.